AxoGen (AXGN) Tops Q4 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/30/2026
- S&P 500, Nasdaq set for best quarter since 2020 despite Iran warÂ
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
- New leader board: Citi refreshes AI compute semiconductor picks
- Honeywell completes aerospace spin-off, splits into 3 companies
AxoGen, Inc. (AXGN) PT Raised to $26 at Canaccord Genuity
February 25, 2025 4:39 PM ESTCanaccord Genuity analyst Kyle Rose raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $26.00 (from $22.00) while maintaining a Buy rating.
The analyst commented, "AXGN posted strong Q4 results, beating top- and bottom-line expectations while again generating cash flow. AXGN notes its positive performance reflects ongoing... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Raymond James
February 25, 2025 4:00 PM ESTRaymond James analyst Jayson Bedford raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $23.00) while maintaining a Outperform rating.
The analyst comments "AXGNs initial 2025 guidance was well above our expectation and the investor day preview (highlighted by an expectation of... More
AxoGen, Inc. (AXGN) PT Raised to $25 at Leerink Partners
February 25, 2025 1:07 PM ESTLeerink Partners analyst Mike Kratky raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $25.00 (from $18.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We are reiterating our Outperform rating on AXGN and increasing our PT to $25 (from $18) following the company's 4Q24 earnings. Consistent with its preannouncement (see HERE),... More

